As the fight against cancer intensifies, a promising new advancement in therapy has emerged through a study combining nadunolimab with pembrolizumab. Reported in the journal Investigational New Drugs, the CIRIFOUR trial explored the efficacy of these drugs in patients with solid tumors. This study
Accurate dietary assessment has long been a challenge in nutritional science, hampered by reliance on self-reported data from methods like questionnaires and food diaries. These are often plagued by inaccuracies due to memory lapses or intentional misreporting, and they frequently lack detailed
The relentless progression of Alzheimer's disease, a debilitating neurodegenerative condition, has been closely linked to the misbehavior of two primary proteins: amyloid-beta and tau. Over the years, scientific efforts have primarily focused on addressing amyloid-beta, leading to some success
Despite increasing investments and rising costs, the pharmaceutical industry's internal rate of return (IRR) from research and development (R&D) has been on a downward trajectory for decades. Recently, however, an analysis indicates the possibility of a resurgence in R&D returns, a
Victoria has embarked on a groundbreaking journey aiming to establish itself as a leading force in global cancer research. Through the Cancer Council Research Fellowships Victoria (CRFV) program, the Victorian Government, in collaboration with Cancer Council Victoria, seeks to reshape the landscape
In a remarkable breakthrough for stem cell research, a team of Australian scientists from Magellan Stem Cells has been celebrated globally for their pioneering work in osteoarthritis clinical research. These researchers have received the esteemed Research Publication of the Year Award from a
